3β-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer

Kristen Evaul, Rui Li, Mahboubeh Papari-Zareei, Richard J. Auchus, Nima Sharifi

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint Dive into the research topics of '3β-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences